Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

Clinical trial NCT00540124 · COMPLETED

Trial details

NCT number: NCT00540124
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2007-10-01
Primary completion: 2008-06-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.